Mackay News
Trial begins to solve complicated treatment problem for child cancer
To get around this, doctors usually strip the disease-fighting T cells and B cells from the donor cell transplant, but this means the transplant recipient is at a higher risk of developing serious infections.
Sorting out the complicated problem has been the work of researchers from QIMR Berghofer Medical Research Institute in Brisbane, who developed a method of treating the T cells from the donor tissue and then introducing them to the recipient child four weeks after the initial transplant.
QIMR’s Professor Rajiv Khanna said they hoped the new method became a “routine” treatment.
Professor Rajiv Khanna, the head of QIMR’s Centre for Immunotherapy and Vaccine Development, said the method removed all the known adverse side-effects of the…
